Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

SLS

SELLAS Life Sciences Group, Inc.

CIK 0001390478 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$15.46
↑ 2.06 (15.37%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$3.12B
P/E Ratio
-96.18
EPS
-0.25
Dividend Yield
Not covered
52W Position
97%
Beta
1.93

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
22.68
P/S
Not covered
EV/Revenue
Not covered
ROE
-23.6%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 97%
$1.39$15.88

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$26.86M
Total Assets
$78.34M
Free Cash Flow
–

Recent news